The latest announcement is out from Poseida Therapeutics ( (PSTX) ).

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Researchers at Helmholtz Munich, in collaboration with colleagues at Tohoku University, have identified a specific redox ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to ...

Well, months after India's drug regulator approved the commercial use of CAR-T cell therapy, a groundbreaking treatment that ...

Real-world results may differ from those seen in clinical trials for CAR T-cell therapy and bispecific antibodies for the ...

Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal ...

A cell therapy developer with operations at the Philadelphia Navy Yard plans reduce its headcount by 33% next year as it ...

T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...